Literature DB >> 30181054

Modeling of the direction modulated brachytherapy tandem applicator using the Oncentra Brachy advanced collapsed cone engine.

Habib Safigholi1, Bob van Veelen2, Yury Niatsetski2, William Y Song3.   

Abstract

PURPOSE: The direction modulated brachytherapy (DMBT) magnetic resonance-compatible tandem applicator, made from a tungsten alloy rod, has six symmetric peripheral grooves, designed specifically to enhance intensity modulation capacity through achieving directional radiation dose profiles. In this work, the directional dose distributions of the DMBT tandem were modeled and calculated with the Oncentra Brachy advanced collapsed cone engine (ACE), which was validated against Monte Carlo (MC) calculations. METHODS AND MATERIAL: The prototype 3D tandem applicator model was created for use in the Oncentra Brachy treatment planning system. The 192Ir source was placed inside a DMBT tandem in one and six channels as a single dwell position (DP) per channel with the same index length, as well as 1 DP in a standard tandem. Dose distributions were calculated in a water medium by both ACE and MC and compared.
RESULTS: For 1DP/6DP inside the DMBT and 1DP inside the standard tandem, respectively, the mean dose differences were 3.5/3.3% and <2.8% with the range of 0.1%-6.5%/0.2%-5% and 0.1%-5%, between ACE and MC, respectively.
CONCLUSIONS: The DMBT tandem is successfully modeled in a commercial treatment planning system. The ACE algorithm is capable of accurately calculating highly directional dose distributions generated by a dense tungsten alloy contained within the DMBT tandem, with agreements achieved within <3.5%.
Copyright © 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced collapsed cone engine; Cervical cancer; Direction modulated brachytherapy; Model-based dose calculation algorithms; Oncentra Brachy

Mesh:

Substances:

Year:  2018        PMID: 30181054     DOI: 10.1016/j.brachy.2018.08.001

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  3 in total

1.  Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the 169 Yb Isotope.

Authors:  Karolyn M Hopfensperger; Quentin Adams; Yusung Kim; Xiaodong Wu; Weiyu Xu; Kaustubh Patwardhan; Bounnak Thammavong; Joseph Caster; Ryan T Flynn
Journal:  Med Phys       Date:  2020-03-13       Impact factor: 4.071

Review 2.  A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy.

Authors:  Yousif A M Yousif; Alexander F I Osman; Mohammed A Halato
Journal:  Phys Eng Sci Med       Date:  2021-06-17

Review 3.  Evolution of Brachytherapy Applicators for the Treatment of Cervical Cancer.

Authors:  Ankur Mourya; Lalit Mohan Aggarwal; Sunil Choudhary
Journal:  J Med Phys       Date:  2021-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.